197 related articles for article (PubMed ID: 22074437)
1. Statin discontinuation in high-risk patients: a systematic review of the evidence.
Gomez Sandoval YH; Braganza MV; Daskalopoulou SS
Curr Pharm Des; 2011 Nov; 17(33):3669-89. PubMed ID: 22074437
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
3. A review of perioperative statin therapy for noncardiac surgery.
Skrlin S; Hou V
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
[TBL] [Abstract][Full Text] [Related]
4. Statin treatment non-adherence and discontinuation: clinical implications and potential solutions.
Phan K; Gomez YH; Elbaz L; Daskalopoulou SS
Curr Pharm Des; 2014; 20(40):6314-24. PubMed ID: 24953391
[TBL] [Abstract][Full Text] [Related]
5. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
[TBL] [Abstract][Full Text] [Related]
6. Non-adherence to statin therapy: a major challenge for preventive cardiology.
Bates TR; Connaughton VM; Watts GF
Expert Opin Pharmacother; 2009 Dec; 10(18):2973-85. PubMed ID: 19954271
[TBL] [Abstract][Full Text] [Related]
7. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
8. Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement.
Banach M; Stulc T; Dent R; Toth PP
Int J Cardiol; 2016 Dec; 225():184-196. PubMed ID: 27728862
[TBL] [Abstract][Full Text] [Related]
9. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality.
Liberopoulos EN; Florentin M; Mikhailidis DP; Elisaf MS
Expert Opin Drug Saf; 2008 Nov; 7(6):717-25. PubMed ID: 18983218
[TBL] [Abstract][Full Text] [Related]
10. Statin use and the risk of CVD events, stroke, and all-cause mortality in patients with diabetes: A systematic review and meta-analysis.
Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2470-2482. PubMed ID: 36064686
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanistic and clinical implications concerning the safety of statin discontinuation.
Jasińska-Stroschein M; Owczarek J; Wejman I; Orszulak-Michalak D
Pharmacol Rep; 2011; 63(4):867-79. PubMed ID: 22001974
[TBL] [Abstract][Full Text] [Related]
12. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
13. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
Reston JT; Buelt A; Donahue MP; Neubauer B; Vagichev E; McShea K
Ann Intern Med; 2020 Nov; 173(10):806-812. PubMed ID: 32956601
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.
Hope HF; Binkley GM; Fenton S; Kitas GD; Verstappen SMM; Symmons DPM
PLoS One; 2019; 14(1):e0201196. PubMed ID: 30653535
[TBL] [Abstract][Full Text] [Related]
15. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
Lavie G; Cohen S
Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
[TBL] [Abstract][Full Text] [Related]
16. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
Chen YH; Feng B; Chen ZW
Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.
de Vries FM; Kolthof J; Postma MJ; Denig P; Hak E
PLoS One; 2014; 9(11):e111247. PubMed ID: 25372483
[TBL] [Abstract][Full Text] [Related]
18. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
19. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.
De Vera MA; Bhole V; Burns LC; Lacaille D
Br J Clin Pharmacol; 2014 Oct; 78(4):684-98. PubMed ID: 25364801
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of Statins: What Are the Risks?
Marrs JC; Kostoff MD
Curr Atheroscler Rep; 2016 Jul; 18(7):41. PubMed ID: 27221503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
